Variable | Non-obese patients (n = 58) | Obese patients (n = 62) | p value |
---|---|---|---|
Clinical characteristics at baseline | |||
Age, years | 54.24 ± 9.85 | 52.03 ± 6.48 | 0.313 |
Female gender, n (%) | 6 (10.34%) | 20 (32.25%) | 0.04 |
Current smoker, n (%) | 46 (79.31%) | 32 (51.6%) | 0.025 |
Hypertension, n (%) | 16 (27.58%) | 34 (54.84%) | 0.032 |
Diabetes, n (%) | 14 (24.13%) | 24 (38.7%) | 0.225 |
Dyslipidemia, n (%) | 14 (24.13%) | 26 (41.93%) | 0.144 |
BMI, kg/m2 | 27.36 ± 1.65 | 33.75 ± 3.81 | < 0.001 |
Systolic BP, mmHg | 121.03 ± 15.08 | 132.42 ± 16.68 | 0.008 |
Diastolic BP, mmHg | 76.38 ± 10.26 | 81.61 ± 9.34 | 0.043 |
METs achieved | 9.74 ± 2.47 | 7.97 ± 2.4 | 0.007 |
Laboratory tests at baseline | |||
Total cholesterol, mg/dl | 170.86 ± 41.16 | 181.00 ± 34.48 | 0.304 |
LDL-C, mg/dl | 95.73 ± 31.51 | 121.63 ± 36.52 | 0.005 |
HDL-C, mg/dl | 39.34 ± 8.28 | 38.13 ± 8.14 | 0.569 |
Triglycerides, mg/dl | 148.86 ± 76.38 | 167.77 ± 60.63 | 0.291 |
Fasting blood sugar, mg/dl | 101.48 ± 24.80 | 109.13 ± 31.10 | 0.299 |
Echocardiographic parameters at baseline | |||
LVEDD, mm | 52.38 ± 4.74 | 52.16 ± 4.51 | 0.856 |
LVESD, mm | 37.28 ± 5.52 | 35.97 ± 4.71 | 0.327 |
LVEF, % | 54.45 ± 8.34 | 56.61 ± 9.47 | 0.353 |